- Home
- GATX vs RNA Comparison
GATX vs RNA Comparison
Compare GATX & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GATX
- RNA
- Stock Information
- Founded
- GATX 1898
- RNA 2012
- Country
- GATX United States
- RNA United States
- Employees
- GATX N/A
- RNA N/A
- Industry
- GATX Transportation Services
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- GATX Consumer Discretionary
- RNA Health Care
- Exchange
- GATX Nasdaq
- RNA Nasdaq
- Market Cap
- GATX 5.2B
- RNA 4.4B
- IPO Year
- GATX N/A
- RNA 2020
- Fundamental
- Price
- GATX $152.87
- RNA $29.31
- Analyst Decision
- GATX Buy
- RNA Strong Buy
- Analyst Count
- GATX 2
- RNA 14
- Target Price
- GATX $172.50
- RNA $68.00
- AVG Volume (30 Days)
- GATX 215.9K
- RNA 1.4M
- Earning Date
- GATX 07-22-2025
- RNA 08-08-2025
- Dividend Yield
- GATX 1.59%
- RNA N/A
- EPS Growth
- GATX 12.52
- RNA N/A
- EPS
- GATX 7.90
- RNA N/A
- Revenue
- GATX $1,627,200,000.00
- RNA $8,927,000.00
- Revenue This Year
- GATX $10.94
- RNA N/A
- Revenue Next Year
- GATX $5.40
- RNA $155.06
- P/E Ratio
- GATX $19.38
- RNA N/A
- Revenue Growth
- GATX 12.07
- RNA N/A
- 52 Week Low
- GATX $127.70
- RNA $21.51
- 52 Week High
- GATX $168.89
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- GATX 50.97
- RNA 42.04
- Support Level
- GATX $151.29
- RNA $31.59
- Resistance Level
- GATX $155.18
- RNA $38.00
- Average True Range (ATR)
- GATX 2.31
- RNA 2.01
- MACD
- GATX -0.45
- RNA -0.59
- Stochastic Oscillator
- GATX 18.89
- RNA 9.67
About GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.